Skip to main content
Top
Published in: Intensive Care Medicine 11/2014

01-11-2014 | Editorial

Antibiotic dosing in the critically ill: asking the same questions but expecting different answers

Authors: P. Póvoa, I. Spriet, J. R. Zahar

Published in: Intensive Care Medicine | Issue 11/2014

Login to get access

Excerpt

The approach of severe sepsis and septic shock has three fundamental steps: early recognition, hemodynamic resuscitation and early empiric antibiotic therapy with focus control if appropriate. Empiric antibiotic therapy involves two decisions: the choice of antibiotics, which depends on the presumed focus and pathogens, and dosing of antibiotics, which should be appropriate along with a correct route and mode of administration [1]. …
Literature
1.
go back to reference Goncalves-Pereira J, Paiva JA (2013) Dose modulation: a new concept of antibiotic therapy in the critically ill patient? J Crit Care 28:341–346PubMedCrossRef Goncalves-Pereira J, Paiva JA (2013) Dose modulation: a new concept of antibiotic therapy in the critically ill patient? J Crit Care 28:341–346PubMedCrossRef
2.
go back to reference De Waele JJ, Lipman J, Akova M, Bassetti M, Dimopoulos G, Kaukonen M, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Udy AA, Starr T, Wallis SC, Roberts JA (2014) Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients. Intensive Care Med 40:1340–1351. doi:10.1007/s00134-014-3403-8 De Waele JJ, Lipman J, Akova M, Bassetti M, Dimopoulos G, Kaukonen M, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Udy AA, Starr T, Wallis SC, Roberts JA (2014) Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients. Intensive Care Med 40:1340–1351. doi:10.​1007/​s00134-014-3403-8
3.
go back to reference Roberts JA, De Waele JJ, Dimopoulos G, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J (2012) DALI: defining antibiotic levels in intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic. BMC Infect Dis 12:152PubMedCrossRefPubMedCentral Roberts JA, De Waele JJ, Dimopoulos G, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J (2012) DALI: defining antibiotic levels in intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic. BMC Infect Dis 12:152PubMedCrossRefPubMedCentral
4.
go back to reference Baptista JP, Udy AA, Sousa E, Pimentel J, Wang L, Roberts JA, Lipman J (2011) A comparison of estimates of glomerular filtration in critically ill patients with augmented renal clearance. Crit Care 15:R139PubMedCrossRefPubMedCentral Baptista JP, Udy AA, Sousa E, Pimentel J, Wang L, Roberts JA, Lipman J (2011) A comparison of estimates of glomerular filtration in critically ill patients with augmented renal clearance. Crit Care 15:R139PubMedCrossRefPubMedCentral
5.
go back to reference Baptista JP, Neves M, Rodrigues L, Teixeira L, Pinho J, Pimentel J (2014) Accuracy of the estimation of glomerular filtration rate within a population of critically ill patients. J Nephrol 27:403–410 Baptista JP, Neves M, Rodrigues L, Teixeira L, Pinho J, Pimentel J (2014) Accuracy of the estimation of glomerular filtration rate within a population of critically ill patients. J Nephrol 27:403–410
6.
go back to reference Goncalves-Pereira J, Povoa P (2011) Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of beta-lactams. Crit Care 15:R206PubMedCrossRefPubMedCentral Goncalves-Pereira J, Povoa P (2011) Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of beta-lactams. Crit Care 15:R206PubMedCrossRefPubMedCentral
7.
go back to reference Roberts JA, Abdul-Aziz MH, Lipman J, Mouton JW, Vinks AA, Felton TW, Hope WW, Farkas A, Neely MN, Schentag JJ, Drusano G, Frey OR, Theuretzbacher U, Kuti JL, International Society of Anti-Infective Pharmacology and the Pharmacokinetics and Pharmacodynamics Study Group of the European Society of Clinical Microbiology and Infectious Diseases (2014) Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. Lancet Infect Dis 14:498–509PubMedCrossRef Roberts JA, Abdul-Aziz MH, Lipman J, Mouton JW, Vinks AA, Felton TW, Hope WW, Farkas A, Neely MN, Schentag JJ, Drusano G, Frey OR, Theuretzbacher U, Kuti JL, International Society of Anti-Infective Pharmacology and the Pharmacokinetics and Pharmacodynamics Study Group of the European Society of Clinical Microbiology and Infectious Diseases (2014) Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. Lancet Infect Dis 14:498–509PubMedCrossRef
8.
go back to reference Dulhunty JM, Roberts JA, Davis JS, Webb SA, Bellomo R, Gomersall C, Shirwadkar C, Eastwood GM, Myburgh J, Paterson DL, Lipman J (2013) Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial. Clin Infect Dis 56:236–244PubMedCrossRef Dulhunty JM, Roberts JA, Davis JS, Webb SA, Bellomo R, Gomersall C, Shirwadkar C, Eastwood GM, Myburgh J, Paterson DL, Lipman J (2013) Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial. Clin Infect Dis 56:236–244PubMedCrossRef
9.
go back to reference De Waele JJ, Carrette S, Carlier M, Stove V, Boelens J, Claeys G, Leroux-Roels I, Hoste E, Depuydt P, Decruyenaere J, Verstraete AG (2014) Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial. Intensive Care Med 40:380–387PubMedCrossRef De Waele JJ, Carrette S, Carlier M, Stove V, Boelens J, Claeys G, Leroux-Roels I, Hoste E, Depuydt P, Decruyenaere J, Verstraete AG (2014) Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial. Intensive Care Med 40:380–387PubMedCrossRef
10.
go back to reference Aubert G, Carricajo A, Coudrot M, Guyomarc’h S, Auboyer C, Zeni F (2010) Prospective determination of serum ceftazidime concentrations in intensive care units. Ther Drug Monit 32:517–519PubMedCrossRef Aubert G, Carricajo A, Coudrot M, Guyomarc’h S, Auboyer C, Zeni F (2010) Prospective determination of serum ceftazidime concentrations in intensive care units. Ther Drug Monit 32:517–519PubMedCrossRef
11.
go back to reference Chapuis TM, Giannoni E, Majcherczyk PA, Chiolero R, Schaller MD, Berger MM, Bolay S, Decosterd LA, Bugnon D, Moreillon P (2010) Prospective monitoring of cefepime in intensive care unit adult patients. Crit Care 14:R51PubMedCrossRefPubMedCentral Chapuis TM, Giannoni E, Majcherczyk PA, Chiolero R, Schaller MD, Berger MM, Bolay S, Decosterd LA, Bugnon D, Moreillon P (2010) Prospective monitoring of cefepime in intensive care unit adult patients. Crit Care 14:R51PubMedCrossRefPubMedCentral
12.
go back to reference Goncalves-Pereira J, Oliveira BS, Janeiro S, Estilita J, Monteiro C, Salgueiro A, Vieira A, Gouveia J, Paulino C, Bento L, Povoa P (2012) Continuous infusion of piperacillin/tazobactam in septic critically ill patients—a multicenter propensity matched analysis. PLoS One 7:e49845PubMedCrossRefPubMedCentral Goncalves-Pereira J, Oliveira BS, Janeiro S, Estilita J, Monteiro C, Salgueiro A, Vieira A, Gouveia J, Paulino C, Bento L, Povoa P (2012) Continuous infusion of piperacillin/tazobactam in septic critically ill patients—a multicenter propensity matched analysis. PLoS One 7:e49845PubMedCrossRefPubMedCentral
13.
go back to reference Mohd Hafiz AA, Staatz CE, Kirkpatrick CM, Lipman J, Roberts JA (2012) Continuous infusion vs. bolus dosing: implications for beta-lactam antibiotics. Minerva Anestesiol 78:94–104PubMed Mohd Hafiz AA, Staatz CE, Kirkpatrick CM, Lipman J, Roberts JA (2012) Continuous infusion vs. bolus dosing: implications for beta-lactam antibiotics. Minerva Anestesiol 78:94–104PubMed
Metadata
Title
Antibiotic dosing in the critically ill: asking the same questions but expecting different answers
Authors
P. Póvoa
I. Spriet
J. R. Zahar
Publication date
01-11-2014
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 11/2014
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-014-3477-3

Other articles of this Issue 11/2014

Intensive Care Medicine 11/2014 Go to the issue